Seven-day vonoprazan-based triple therapy as first-line Helicobacter pylori treatment in comparison with extended sequential therapy.

Yu-Tse Chiu,Fu-Jen Lee,Chen-Ya Kuo,Yang-Chao Lin,Kai-Shun Liang,Liang-Wei Tseng,Yu-Tsung Chen,Chi-Yang Chang

JGH open : an open access journal of gastroenterology and hepatology（2023）

引用 0|浏览4

暂无评分

摘要

Seven-day vonoprazan-based triple therapy with high-dose amoxicillin is a potential first-line anti- regimen alternative to current standard treatment, with the advantages of simplicity, short treatment duration, low pill burden, and fewer major adverse effects.

查看译文

关键词

Helicobacter pylori,antibacterial agents,potassium‐competitive acid blocker,proton pump inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要